tyrosine has been researched along with Benign Neoplasms in 240 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 60 (25.00) | 18.7374 |
| 1990's | 12 (5.00) | 18.2507 |
| 2000's | 60 (25.00) | 29.6817 |
| 2010's | 70 (29.17) | 24.3611 |
| 2020's | 38 (15.83) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimori, I; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
| Matsuda, T; Oritani, K | 1 |
| Changeux, JP; Hunter, T; Taylor, SS | 1 |
| Chen, PJ; Zhang, YT | 1 |
| Amani, AM; Dehaen, W; Ramezanpour, S; Shiri, P | 1 |
| Abbate, V; Floresta, G | 1 |
| Dai, Z; Dharmarpandi, J; Hudgins, H; Jiang, P; Kamat, A; Liu, X; Naguib, T; Smalligan, T; Tang, S; Zhou, X | 1 |
| Kaur, N; Kumar, D; Kumar, V; Sahu, S; Sharma, A; Sharma, V; Wadhwa, P | 1 |
| Bustuoabad, OD; Chiarella, P; Duarte, A; Montagna, DR; Rearte, B; Ruggiero, RA; Vermeulen, M | 1 |
| Feng, Y; Jin, X; Liu, J; Peng, P; Qu, Y; Shu, H; Wang, L; Wang, Y; Wei, M; Xia, M | 1 |
| Gędaj, A; Krzyścik, MA; Opaliński, Ł; Otlewski, J; Porębska, N; Poźniak, M; Zakrzewska, M; Żukowska, D | 1 |
| Anwar, S; Hasan, GM; Hassan, MI; Islam, A; Shahwan, M | 1 |
| Afzal, O; Al-Abbasi, FA; Alfawaz Altamimi, AS; Alharbi, KS; Almalki, WH; Alzarea, SI; Dua, K; Gupta, G; Javed Shaikh, MA; Kazmi, I; Singh, SK | 1 |
| Asmamaw, MD; Liu, HM; Shi, XJ; Zhang, LR | 1 |
| Qiu, X; Shen, C; Wu, X; Yang, L; Zhang, X; Zhao, D; Zhao, W | 1 |
| Li, Q; Li, S; Wang, Y; Yang, Y; Zhao, Y | 1 |
| Daly, RJ; Ernst, M; Klein, O; Scott, AM | 1 |
| Jiang, S; Qian, W; Sun, X; Wu, Q | 1 |
| Cheon, H; Jackson, MW; Stark, GR; Wang, Y; Wightman, SM | 1 |
| Bian, J; Chen, P; Lin, Y; Long, J; Sang, X; Wang, A; Wang, H; Yang, X; Zhao, H | 1 |
| Besch, A; Marsiglia, WM; Mohammadi, M; Traaseth, NJ; Zhang, Y | 1 |
| Baltoumas, FA; Filis, G; Iconomidou, VA; Litou, ZI; Spanogiannis, G | 1 |
| Brunocilla, C; Console, L; Indiveri, C; Rovella, F | 1 |
| Chandrasekar, MJN; Nagarjuna, P; Nanjan, MJ; Patnaik, SK; Swaroop, AK | 1 |
| Kan, Y; Kim, Y; Miller, WT; Paung, Y; Seeliger, MA | 1 |
| Bi, W; Du, J; Fang, H; Hou, X; Li, K; Li, X; Liang, X; Yu, D; Zhang, J; Zhang, X; Zhao, H; Zhao, Z | 1 |
| Fazelinia, H; Griswold-Prenner, I; Hall, ZW; Ischiropoulos, H; Kashyap, AK; Mazhar, S | 1 |
| Im, W; Ladokhin, AS; Park, S; Rizzo, S; Sikorski, E; Thévenin, D; Vasquez-Montes, V | 1 |
| Al Abdulmonem, W; Alhumaydhi, FA; Alrouji, M; Anwar, S; Atiya, A; Majrashi, TA; Shahwan, M; Shamsi, A; Sharaf, SE; Zari, A; Zari, TA | 1 |
| Avelar, RA; Brautigan, DL; Bryson, B; DiFeo, A; Gingras, AC; Haider, S; Jackson, M; Leonard, D; Narla, G; O'Connor, CM; Sangodkar, J; Schlatzer, D; Taylor, SE; Tokala, E; Upadhyay, A; Wang, Z; Westermarck, J; Wiredja, D; Xu, W | 1 |
| Chi, D; He, Z; Lin, X; Liu, H; Sun, J; Wang, Y; Wang, Z; Wu, X; Xu, Z | 1 |
| Babes, A; Ionescu, AE; Maier, GL; Manolache, A; Mentel, M; Neacsu, C; Selescu, T; Szedlacsek, SE | 1 |
| Hajicek, N; Harden, TK; Huang, W; Keith, NC; Siraliev-Perez, E; Sondek, J; Temple, BR; Zhang, Q | 1 |
| Eskelinen, M; Holopainen, A; Kaaronen, V; Kokki, H; Kokki, M; Kuosmanen, V; Rahkola, D; Ruottinen, M; Saimanen, I; Selander, T | 1 |
| Dickson, FH; Nabi, IR; Timmins, LR; Wong, TH | 1 |
| Li, CP; Lu, YX; Zhang, YP; Zhao, H; Zhao, YT; Zi, CT | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Buday, L; Vas, V | 1 |
| Paoli, P; Pardella, E; Pranzini, E; Raugei, G; Taddei, ML | 1 |
| Lyakisheva, A; Pathmanathan, S; Saraon, P; Snider, J; Stagljar, I; Wong, V | 1 |
| Chang, MS; Chou, NL; Lee, JY; Lin, HW; Shih, TW | 1 |
| Hou, WH; Sun, ZJ; Wang, HJ; Wang, YX; Wu, Y; Yu, M; Yuan, QY | 1 |
| Grindheim, AK; Saraste, J; Vedeler, A | 1 |
| Guo, YR; Hawke, D; He, J; Lee, JH; Li, XJ; Liu, K; Liu, R; Lu, Z; Lyu, J; Qian, X; Tan, L; Tao, YJ; Wang, Y; Xia, Y; Xing, D; Yang, P; Yin, Z; Zheng, Y | 1 |
| Finegan, KG; Giurisato, E; Gray, NS; Lonardi, S; Pearson, A; Russo, I; Telfer, B; Tournier, C; Vermi, W; Wang, J; Wang, W; Xia, Z; Xu, Q | 1 |
| Dhawan, A; Kansara, K; Pandya, A; Patel, P; Savaliya, R; Shah, D; Singh, S | 1 |
| Aluri, R; Jayakannan, M; Joshi, DC; Saxena, S | 1 |
| Chevassut, T; Dempke, WCM; Fenchel, K; Uciechowski, P | 1 |
| Cao, X; Gao, YN; Ke, AQ; Li, ZF; Liu, AD; Liu, JY; Luo, DN; Xu, H; Yu, YQ | 1 |
| Li, Y; Liu, Z; Pang, X; Qian, X; Song, X; Wang, Y; Yin, Y; Zhang, Y; Zheng, Y | 1 |
| Joubert, C; Lafanechère, L; Michallet, S; Nolte, E; Peronne, L; Ramirez-Rios, S; Ribba, AS; Sadoul, K | 1 |
| Chen, F; Chen, Z; Ding, C; Feng, XH; Gu, S; Ji, H; Ji, J; Li, H; Li, Y; Liang, T; Lin, X; Liu, T; Malkoski, S; Qin, J; Qin, L; Shen, L; Wang, Y; Wu, H; Xiao, M; Xu, P; Xu, Y; Yu, Y; Zhang, Q; Zhao, B; Zhu, Y; Zu, Y | 1 |
| Blanco, L; Blanco-Franco, L; Calvo, PA; Díaz, M; Díaz-Talavera, A; González-Acosta, D; Guerra, S; Martínez-Jiménez, MI; Méndez, J; Sastre-Moreno, G | 1 |
| Evans, TRJ; Jones, R; Montezano, AC; Neves, KB; Rios, FJ; Touyz, RM | 1 |
| Chen, YG; Shi, Q | 1 |
| Gao, H; Li, W; Liang, J; Liu, R; Tao, B; Wang, C; Wang, X; Yang, W; Yang, Z; Zhang, Y | 1 |
| Christen, KE; Davis, RA; Kennedy, D | 1 |
| Yu, JS | 1 |
| Endou, H; Kusuhara, H; Sugiyama, Y; Toyoshima, J; Wempe, MF | 1 |
| Critton, DA; Grotegut, S; Tautz, L | 1 |
| Aguiar, M; Alečković, M; Arellano, M; Boggon, TJ; Britton, LM; Chen, H; Chen, J; Devi, N; Elf, S; Fan, J; Gaddh, M; Garcia, BA; Gu, TL; Hitosugi, T; Kaluz, S; Kang, HB; Kang, S; Kang, Y; Khoury, HJ; Khuri, FR; Lonial, S; Lonning, S; Mohammadi, M; Seo, JH; Shan, C; Tucker, M; Van Meir, EG; Xie, J | 1 |
| Dudem, S; Jain, N; Kalivendi, SV; Vangala, JR | 1 |
| Chan, A; Das, V; Kanakkanthara, A; Miller, JH | 1 |
| Gao, Y; Hu, B; Jiao, BH; Liu, JT; Liu, XY; Lu, XL; Zhang, JP | 1 |
| Bruchard, M; Ghiringhelli, F | 1 |
| Aguiar, M; Arellano, M; Boggon, TJ; Chung, TW; Elf, S; Fan, J; Gu, TL; Hitosugi, T; Kang, HB; Khoury, HJ; Khuri, FR; Lonning, S; Shan, C; Shin, DM; Xie, J | 1 |
| Eli, M; Kong, B; Mamtimin, B; Turahun, A; Upur, H | 1 |
| Huang, Y; Loh, T; Low, IC; Pervaiz, S; Virshup, DM | 1 |
| Aydın, R; Çinkılıç, N; Gençkal, HM; İnci, D; Vatan, Ö; Yılmaz, D; Zorlu, Y | 1 |
| Alwan, WS; Hampannavar, GA; Jain, KS; Karpoormath, R; Karunanidhi, S; Palkar, MB; Patel, HM; Rane, RA; Shaikh, MS; Thapliyal, N | 1 |
| Du, X; Xu, B; Zhou, J | 1 |
| Černoch, P; Černochová, Z; Hrubý, M; Kučka, J; Petrova, S; Štěpánek, P | 1 |
| Gu, L; Lee, S; Li, GM; Li, JY; Ortega, J; Tong, D | 1 |
| Belfiore, A; Iozzo, RV; Malaguarnera, R; Morcavallo, A; Morrione, A; Nicolosi, ML; Sacco, A; Spatuzza, M; Vella, V; Vigneri, R; Voci, C; Xu, SQ | 1 |
| Li, JX; Miao, ZH; Wang, Y; Wang, YQ | 1 |
| Nagase, H; Ozaki, T; Shimozato, O | 1 |
| Bergmeier, W; Lee, RH | 1 |
| Cai, Q; Charles, S; Fu, X; Jin, Y; Kamarajugadda, S; Lim, S; Lu, J; Shenoy, AK; Tan, M; Tarrash, M; Trevino, JG; Zhang, Y | 1 |
| Campos, AR; Donoghue, DJ; Meyer, AN; Motamedchaboki, K; Nelson, KN; Siari, A | 1 |
| Bedi, PMS; Kaur, M; Nepali, K; Ojha, R; Sharma, S; Singh, H; Singh, J | 1 |
| de Vinci Kanda Kupa, L; Drewes, CC; Farsky, SH; Stefani, HA; Vasconcelos, SN | 1 |
| Bian, K; Keidar, M; Murad, F; Nourmohammadi, N; Sherman, JH; Yan, D | 1 |
| Backstrom, I; Bally, MB; Leung, AW | 1 |
| Dohmae, N; Hamamoto, R; Matsuo, Y; Nakakido, M; Nakamura, Y; Simone, C; Suzuki, T; Tsurita, G; Watanabe, T; Yoshioka, Y | 1 |
| Li, YF; Liu, Y; Long, YH; Wang, SQ; Zhang, JH | 1 |
| Cai, Y; Chen, A; Han, A; Huang, H; Huang, L; Ji, Z; Jiang, B; Jin, M; Li, Q; Li, X; Lin, F; Ma, H; Suleman, M; Sun, X; Tian, F; Wang, S; Wu, Y; Xie, C; Zhang, J; Zhang, N; Zhao, Q; Zhao, W; Zhou, H; Zhou, L; Zhou, Y | 1 |
| Cai, WS; Chen, L; Wang, G; Wang, Y | 1 |
| Fu, LW; Zhang, JY | 1 |
| FRIEDBERG, F; GREENBERG, DM; WINNICK, T | 1 |
| Durbin, JE; Koromilas, AE; Raven, JF; Wang, S | 1 |
| Enkhbaatar, P; Herndon, DN; Maybauer, DM; Maybauer, MO; Murthy, KG; Nakano, Y; Salzman, AL; Szabó, C; Traber, DL; Traber, LD; Westphal, M | 1 |
| Anaganti, S; Carlomagno, F; Guida, T; Kjaer, S; McDonald, NQ; Provitera, L; Ryan, AJ; Santoro, M | 1 |
| Hunter, T | 2 |
| Connolly, Y; Gorgoulis, VG; Liontos, M; Malliri, A; Rooney, C; Whetton, AD; Woodcock, SA; Zoumpourlis, V | 1 |
| Asai, T; Fukumoto, D; Oku, N; Sakai, K; Tsukada, H; Urakami, T | 1 |
| Geerts, T; Göhlmann, HW; Janssen, B; King, P; Lavrijssen, T; Page, M; Perera, T; Rockx, C; Talloen, W; Versele, M | 1 |
| He, Y; Li, G; Liu, H; Peng, C; Qi, C; Qiao, Y; Wang, X; Xu, J; Zhang, S | 1 |
| Ahn, SH; Cheon, GJ; Choi, CW; Chun, KS; Kang, JH; Lee, TS; Lim, SM; Moon, BS | 1 |
| Alfteimi, A; Forstner, CV; Henze, E; Lützen, U; Meller, B; Zuhayra, M | 1 |
| Dang, CV | 1 |
| Boggon, TJ; Cantley, LC; Chen, GZ; Chen, J; Chung, TW; Dong, S; Elf, S; Gilliland, DG; Gu, TL; Hitosugi, T; Kang, S; Kaufman, J; Khuri, FR; Lonial, S; Lythgoe, K; Polakiewicz, RD; Roesel, JL; Vander Heiden, MG; Wang, X; Xie, J | 1 |
| Cianchi, F; De Giuli, P; Fasolis, G; Masini, E; Papucci, L; Pastorekova, S; Perigli, G; Peruzzi, B; Pini, A; Puccetti, L; Supuran, CT; Vinci, MC | 1 |
| Gomez-Cambronero, J | 1 |
| Gunjan, A; Singh, RK | 1 |
| Ingham, RJ; Lai, R; Li, L; McMullen, T; Wang, P; Wu, F; Young, LC; Zhang, J | 1 |
| Ammer, AG; Hayes, KE; Kelley, LC; Martin, KH; Weed, SA | 1 |
| Dubé, N; Hardy, S; Julien, SG; Tremblay, ML | 1 |
| Husain, D; Meyer, RD; Rahimi, N | 1 |
| Lee, D; Shim, H; Zhu, A | 1 |
| Bald, L; Fayadat-Dilman, L; Grein, J; Janatpour, MJ; Vanderlaag, K; Wagner, J; Wang, W | 1 |
| Appleton, BA; Blank, J; Buck, E; Degenkolbe, E; Drueckes, P; Furet, P; Haasen, D; Hofmann, F; Jones, MD; McCarthy, C; Monahan, JE; Ruddy, DA; Schoepfer, J; Sellers, WR; Tiedt, R; Wagner, S; Wartmann, M | 1 |
| Fang, H; Feng, J; Liu, C; Xu, W; Zhang, Y | 1 |
| Boggon, TJ; Chen, GZ; Chen, J; Chung, TW; Fan, J; Ge, Q; Gu, TL; Hitosugi, T; Kang, S; Khuri, FR; Lonial, S; Polakiewicz, RD; Xie, J | 1 |
| Dalbay, M; Lim, SV; McDuff, FK; Turner, SD | 1 |
| Bushman, J; Garbuzenko, OB; Gounder, MK; Kohn, J; Minko, T; Sheihet, L | 1 |
| Boggon, TJ; Chen, GZ; Chen, J; Chung, TW; Fan, J; Fu, H; Ge, Q; Gu, TL; Hitosugi, T; Kang, S; Khuri, FR; Lonial, S; Lythgoe, K; Polakiewicz, RD; Roesel, JL; Wang, X; Xie, J | 1 |
| Angata, K; Bao, X; Chanda, SK; Courtneidge, S; Fukuda, M; Yoneyama, T | 1 |
| Bruzzo, J; Bustuoabad, OD; Chiarella, P; Meiss, RP; Pasqualini, CD; Ruggiero, RA | 1 |
| Bouvet, V; Tam, PH; Wang, M; Wuest, F; Wuest, M | 1 |
| Bruzzo, J; Chiarella, P; Meiss, RP; Ruggiero, RA | 1 |
| Endo, K; Endou, H; Kaira, K; Kanai, Y; Kitashoji, T; Nagamori, S; Nakao, H; Ohgaki, R; Oriuchi, N; Sakurai, H; Tanaka, H; Tominaga, H; Wiriyasermkul, P | 1 |
| Chen, D; Fu, J; Liu, C; Luo, L; Xin, Y; Xu, Y; Yin, Z; Zhao, B; Zhao, Z; Zhou, J | 1 |
| Guan, JL; Ritt, M; Sivaramakrishnan, S | 1 |
| Chun, SJ; Habib, AA; Neel, BG; Vartanian, T | 1 |
| Gan, M; Luo, L; Tang, G; Tang, X; Wang, M | 2 |
| Bacus, S; Brattain, MG; deGraffenried, L; Hammond, LA; Hidalgo, M; Kreisberg, JI; Malik, SN; Rizzo, J; Rowinsky, EK; Siu, LL | 1 |
| Bekele, BN; Bucana, CD; Doan, DD; Fidler, IJ; Greenberg, JS; Holsinger, FC; Jasser, SA; Myers, JN; Schiff, BA; Swan, EA; Younes, MN | 1 |
| BULLOCK, WK | 1 |
| TANINO, J | 1 |
| GIRKIN, G; KAMPSCHMIDT, RF | 1 |
| DAVYDOVA, SIa | 1 |
| LEUPOLD, E | 1 |
| BRACKENRIDGE, CJ | 1 |
| SMIRNOVA, EV | 1 |
| ERB, W; HEMPEL, K | 1 |
| ADZHIEV, BL | 1 |
| CHIRIGOS, MA; FANNING, GR; GUROFF, G | 1 |
| ASANO, S; ISHIGURO, I; KONO, R; KUZUYA, H; MORISHIMA, K; OKAMOTO, M; TAKATORI, K | 1 |
| GENTY, N; MELONI, GA; VENDRELY, R | 1 |
| BRADA, Z; KOCENT, A; PECHAN, Z; TOBISKA, J | 2 |
| LORINCZ, AB; RYAN, WL | 1 |
| SCOLARI, EG | 1 |
| DIMITRIADOU, A; FRASER, R; TURNER, PC | 1 |
| CAMERON, E; CAMPBELL, A | 1 |
| HALES, IB; MYHILL, J; REEVE, TS; RICHARDS, M; STANLEY, PG | 1 |
| LEVINE, RJ; LOVENBERG, W; SJOERDSMA, A | 1 |
| GJESSING, LR | 1 |
| VARDANIAN, SA | 1 |
| MATSUMOTO, K; NAKATA, K; NAKATA, Y; SAKAMOTO, Y; SUEMATSU, T | 1 |
| ALLAN, JD; IRELAND, JT; MILNER, J; MOSS, AD | 1 |
| KLATT, O; MILNER, AN; STEHLIN, JS; YOUNG, SE | 1 |
| Dahlin, A; Disis, ML; Hellström, I; Hellström, KE; Knutson, KL; Pullman, J; Scholler, N | 1 |
| Angeloni, D; Danilkovitch-Miagkova, A; Leonard, EJ; Lerman, MI; Miagkov, A | 1 |
| Bergan, RC; Crowell, JA; Gallot, L; Glover, K; Goetz, A; Hayes, SA; Hernandez, L; Huang, X; Jovanovic, BD; Lieberman, R; Llorens, V; Poisson, BA; Quinn, M; Shapiro, A; Takimoto, CH | 1 |
| Brutkiewicz, RR; Cho, S; Hwang, YK; Lin, Y; Roberts, TJ; Sriram, V | 1 |
| Foster, DA; Jackson, DN | 1 |
| Cheong, C; Cho, JM; Jee, J; Jeon, YH; Kim, KA; Lee, C; Lee, TG; Lee, W; Ro, S; Sheen, MR; Song, JS; Yamazaki, T | 1 |
| Druker, BJ; Epstein, RJ; Lim, YP; Ooi, LL; Wong, CY | 1 |
| SCOTT, KG; STONE, RS | 1 |
| Cao, P; Gronda, M; Hedley, DW; Jacobberger, JW; Pham, NA; Schimmer, AD | 1 |
| Comb, MJ; Goss, VL; Guo, A; Lee, KA; Moritz, A; Polakiewicz, RD; Rush, J; Spek, EJ; Zha, XM; Zhang, H | 1 |
| Enns, A; Fisch, KM; Gassmann, P; Haier, J; Nicolson, GL; von Sengbusch, A | 1 |
| Clarke, AR; Matthews, JR | 1 |
| Chiariotti, L; Florio, T; Fusco, A; Iuliano, R; Pera, IL; Santoro, M; Schettini, G; Susini, C; Trapasso, F; Viglietto, G | 1 |
| Bauer, D; Bröer, S; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Pauleit, D; Schaden, W; Stoffels, G; Tellmann, L | 1 |
| Wang, MH; Xu, XM; Zhou, YQ | 1 |
| Ding, J; Li, L; Lin, L; Sun, P; Tian, F; Tong, Y; Yi, Y; Zhang, S; Zhang, X | 1 |
| Chiarle, R; Inghirami, G; Levy, DE; Piva, R; Schlessinger, K; Simmons, WJ | 1 |
| Akaike, T; Akuta, T | 1 |
| Larocque, D; Lukong, KE; Richard, S; Tyner, AL | 1 |
| Bryant, I; Coffing, SL; Gilmore, JL; Hom, DL; Lim, JK; Negash, K; Ono, MY; Riese, DJ; VanBrocklin, HF | 1 |
| Maioli, E; Vittoria, F | 1 |
| Birchmeier, W; Brembeck, FH; Rosário, M | 1 |
| Huber, P; Vilgrain, I; Wallez, Y | 1 |
| Böhmer, FD; Hellberg, C; Ostman, A | 1 |
| Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM | 1 |
| Tonks, NK | 1 |
| Bonventre, JV; Klose, C; Kuehn, EW; Muehlfeit, M; van de Weyer, PS; Walz, G | 1 |
| Chakrabarty, AM; Chaudhari, A; Cho, W; Das Gupta, TK; Fialho, AM; Granja, AT; Hashimoto, W; Mahfouz, M; Schlarb-Ridley, B; Yamada, T; Zhu, Y | 1 |
| Kessler, H; Knör, S; Modlinger, A; Poethko, T; Schottelius, M; Wester, HJ | 1 |
| Addepalli, R; Avery, VM; Boyle, A; Buchanan, MS; Carroll, AR; Chen, H; Fechner, GA; Hooper, JN; Quinn, RJ; Simpson, MM; Su, N | 1 |
| Chen, RK; Chen, YY; Hsu, SF; Khoo, KH; Lee, CL; Lou, YW; Meng, TC; Tonks, NK | 1 |
| Helin, J; Itkonen, O; Ivanov, KI; Kalkkinen, N; Saarinen, J; Stenman, UH; Valmu, L | 1 |
| ZAVALA MUNIZ, J | 1 |
| Abe, M; Ishii, K; Shimoda, M; Shirasuna, K; Sugiura, T; Takahashi, M | 1 |
| Heckmann, D; Kessler, H; Laufer, B; Meyer, A; Stragies, R; Zahn, G | 1 |
| Grossman, H; Kirks, DR; Merten, DF | 1 |
| Magee, PN; Nyce, J; Weinhouse, S | 1 |
| Lévy, JP | 1 |
| Bennegård, K; Edén, E; Ekman, L; Lindmark, L; Lundholm, K | 1 |
| Hill, MJ | 1 |
| Batist, G; Bistrian, BR; Blackburn, GL; Bothe, A; Kawamura, I; Keenan, RA; Moldawer, LL | 1 |
| Burke, TR | 1 |
| Di Fiore, PP; Grazia Borrello, M; Lanfrancone, L; Mele, S; Pelicci, G; Pelicci, PG; Romano, A; Salcini, AE; Segatto, O | 1 |
| Hamburger, AW; Mishra, S | 1 |
| Bartlett, K; Brock, C; Craft, AW; Daley, SE; Halliday, D; Hetherington, C; Kernahan, J; Pearson, AD; Price, L; Wyllie, RA | 1 |
| Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Willemsen, AT | 1 |
| Hoekstra, HJ; Kole, AC; Nieweg, OE; Pruim, J; Schraffordt Koops, H; Vaalburg, W; van Ginkel, RJ | 1 |
| Amed, K; Endo, K; Higuchi, T; Inoue, T; Muhammad, S; Tomiyoshi, K; Yang, D | 1 |
| Haier, J; Nasralla, M; Nicolson, GL | 1 |
| Idriss, HT | 1 |
| Hamaguchi, M; Kamei, T; Machida, K; Matsuda, S; Nimura, Y; Senga, T; Yamada, I; Yoshii, S | 1 |
| de Vries, EG; Jager, PL; Langen, KJ; Piers, DA; Pruim, J; Vaalburg, W | 1 |
| Bhaumik, S; Khar, A; Mitra, R; Varalakshmi, C | 1 |
| Hulderman, T; Luster, MI; Simeonova, PP; Wang, S | 1 |
| Hayakawa, T; Hyuga, M; Hyuga, S; Kawanishi, T; Kawasaki, N; Ohta, M; Shibayama, R; Yamagata, S; Yamagata, T | 1 |
| Lynch, DH; Yang, XD | 1 |
| Chawla, RK; Rudman, D; Wadsworth, AD | 1 |
| Kokolis, N; Ziegler, I | 1 |
| Hradec, J | 1 |
| Chesterman, CN; Khachigian, LM; Owensby, DA | 1 |
| Matsumoto, H; Mori, S | 1 |
| Edén, E; Hyltander, A; Lundholm, K; Warnold, I | 1 |
| Nagafuchi, A; Tsukita, S | 1 |
| Iwamura, K; Noguchi, K; Ogawa, R; Ohtsuka, M; Watanabe, Y | 1 |
| Chiado'Piat, L; Cirillo, D; Comoglio, PM; Di Renzo, MF; Giordano, S; Naldini, L | 1 |
| Borisenko, SN; Kasymova, GA; Troitskiĭ, GV | 1 |
| Landel, AM; Lo, CC; Meguid, MM | 1 |
| Laberge, C; Lescault, A; Tanguay, RM | 1 |
| Baĭkova, VN; Rybal'chenko, VG; Shevchenko, VE; Sotnikova, EN; Vares, IM | 1 |
| Ivanova, VD; Shevchenko, VE; Sotnikova, EN; Vaĭkova, VN; Vares, IM | 1 |
| Ben-Ze'ev, A | 1 |
| Johnson, PM; Risk, JM | 1 |
| Hammond, WG; Landel, AM; Meguid, MM | 1 |
| Brennan, MF; Burt, ME; Gorschboth, CM; Norton, JA; Wesley, RA | 1 |
| Folkers, K | 1 |
| Bhide, SV; Ranadive, KJ; Sheth, NA; Wagle, MM | 1 |
| Ewen, SW; Pearse, AG; Polak, JM | 1 |
| Käser, H | 1 |
| DeWys, WD; Hall, TC | 1 |
| Edelstein, L; Hamada, G; Niebauer, G; Okun, MR | 1 |
| Hahn, K; Jesdinsky, HJ; Ladner, HA | 1 |
| Hersh, EM; Ohno, R | 1 |
| Brada, Z; Kolárová, M; Tobiska, J | 1 |
| Kopin, IJ; Kvetnanský, R; Sigalos, GL; Silbergeld, S; Weise, VK | 1 |
| Brada, Z; Kocent, A; Tobiska, J; Vermousek, I | 1 |
| Montenero, P; Monti, A | 1 |
57 review(s) available for tyrosine and Benign Neoplasms
| Article | Year |
|---|---|
Possible Therapeutic Applications of Targeting STAP Proteins in Cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Proteins; Carcinogenesis; Humans; Neoplasm Proteins; Neoplasms; Phosphoproteins; Protein-Tyrosine Kinases; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Tumor Suppressor Proteins; Tyrosine | 2021 |
Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis.
Topics: Cell Transformation, Neoplastic; Humans; Neoplasms; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Tyrosine | 2022 |
A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy.
Topics: Humans; Indazoles; Neoplasms; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines; Sulfonamides; Tyrosine | 2022 |
Recent progress in the imaging of c-Met aberrant cancers with positron emission tomography.
Topics: Cell Transformation, Neoplastic; Humans; Neoplasms; Positron-Emission Tomography; Tyrosine | 2022 |
Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review.
Topics: Antineoplastic Agents; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Tyrosine | 2023 |
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Humans; Microtubules; Neoplasms; Neurodegenerative Diseases; NF-kappa B; Phosphates; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Serine; Threonine; TOR Serine-Threonine Kinases; Tyrosine | 2022 |
An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy.
Topics: Animals; Antineoplastic Agents; ErbB Receptors; Humans; Mice; Neoplasms; Precision Medicine; Signal Transduction; Tyrosine | 2022 |
A comprehensive review of SHP2 and its role in cancer.
Topics: Antineoplastic Agents; Carcinogenesis; Cytokines; Humans; MicroRNAs; Neoplasms; Phosphatidylinositol 3-Kinases; Programmed Cell Death 1 Receptor; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Tyrosine | 2022 |
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective.
Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Tumor Microenvironment; Tyrosine | 2022 |
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.
Topics: Humans; Immune Checkpoint Inhibitors; Neoplasms; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Tumor Microenvironment; Tyrosine | 2022 |
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Biological Products; Humans; Immune Checkpoint Inhibitors; Immunoconjugates; Neoplasms; Pharmaceutical Preparations; Tyrosine; United States; United States Food and Drug Administration | 2022 |
How cancer cells make and respond to interferon-I.
Topics: Humans; Interferon-Stimulated Gene Factor 3; Interferon-Stimulated Gene Factor 3, gamma Subunit; Interferons; Neoplasms; Signal Transduction; Tyrosine | 2023 |
Unveiling the human nitroproteome: Protein tyrosine nitration in cell signaling and cancer.
Topics: Animals; Humans; Neoplasms; Phosphorylation; Proteins; Signal Transduction; Tyrosine | 2023 |
Tyrosine phosphorylation of tumor cell caveolin-1: impact on cancer progression.
Topics: Animals; Caveolin 1; Cell Movement; Disease Progression; Focal Adhesions; Humans; Neoplasms; Phosphorylation; src-Family Kinases; Tyrosine | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation.
Topics: Animals; Genes, ras; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins p21(ras); Tyrosine | 2020 |
Role of tyrosine phosphorylation in modulating cancer cell metabolism.
Topics: Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Tyrosine | 2020 |
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches.
Topics: Animals; Humans; Molecular Targeted Therapy; Neoplasms; Oncogenes; Protein Kinase Inhibitors; Tyrosine | 2021 |
Protein phosphorylation and its role in the regulation of Annexin A2 function.
Topics: Annexin A2; Cell Transformation, Neoplastic; Exosomes; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Ribonucleoproteins; S100 Proteins; Serine; Tyrosine | 2017 |
Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Topics: Animals; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Molecular Targeted Therapy; Neoplasms; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; Structure-Activity Relationship; Treatment Outcome; Tyrosine | 2018 |
[On the road to deciphering the tubulin code: focus on acetylation and detyrosination].
Topics: Acetylation; Acetyltransferases; Animals; Humans; Neoplasms; Nervous System Diseases; Protein Processing, Post-Translational; Tubulin; Tyrosine | 2018 |
From discovery of tyrosine phosphorylation to targeted cancer therapies: The 2018 Tang Prize in Biopharmaceutical Science.
Topics: Antibodies, Monoclonal; Cell Proliferation; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Tyrosine | 2019 |
Protein tyrosine phosphatases: structure, function, and implication in human disease.
Topics: Catalysis; Catalytic Domain; Crystallography, X-Ray; Drug Design; Humans; Neoplasms; Phosphorylation; Protein Tyrosine Phosphatases; Substrate Specificity; Tyrosine | 2013 |
Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance.
Topics: Antineoplastic Agents; Carcinogenesis; Drug Resistance, Neoplasm; Humans; Microtubules; Neoplasms; Peptide Synthases; Protein Processing, Post-Translational; Signal Transduction; Tubulin; Tyrosine | 2014 |
[Impact of chemotherapies on immunosuppression and discovery of new therapeutic targets].
Topics: Animals; Carrier Proteins; CD4-Positive T-Lymphocytes; Deoxycytidine; Epoxy Compounds; Fluorouracil; Gemcitabine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammasomes; Interleukin-17; Interleukin-1beta; Mice; Myeloid Cells; Neoplasms; Neovascularization, Pathologic; NLR Family, Pyrin Domain-Containing 3 Protein; Tyrosine | 2014 |
An insight into purine, tyrosine and tryptophan derived marine antineoplastic alkaloids.
Topics: Alkaloids; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aquatic Organisms; Humans; Neoplasms; Purines; Tryptophan; Tyrosine | 2015 |
[The role of tyrosine phosphorylation of cancer stem cell marker CD133 in malignant tumor progression].
Topics: AC133 Antigen; Animals; Antigens, CD; Biomarkers; Glycoproteins; Humans; Neoplasms; Neoplastic Stem Cells; Peptides; Phosphorylation; Tyrosine | 2015 |
Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
Topics: Amino Acid Motifs; Animals; Blood Platelets; Embryonic Development; Glycoproteins; Hemorrhage; Hemostasis; Humans; Immunoreceptor Tyrosine-Based Activation Motif; Inflammation; Lectins, C-Type; Lymphatic Vessels; Membrane Glycoproteins; Mice; Mucins; Neoplasms; Permeability; Platelet Activation; Platelet Membrane Glycoproteins; Protein Domains; Signal Transduction; Tyrosine | 2016 |
Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.
Topics: Animals; Drug Design; Humans; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Purines; Structure-Activity Relationship; Tyrosine | 2016 |
Sulfonation, an underexploited area: from skeletal development to infectious diseases and cancer.
Topics: Animals; Bone Development; Cell Nucleus; Communicable Diseases; Humans; Multienzyme Complexes; Neoplasms; Protein Processing, Post-Translational; Sulfate Adenylyltransferase; Tyrosine; Xenobiotics | 2016 |
[Advance of several types of important marine antitumor drugs].
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Products; Bryostatins; Cell Line, Tumor; Depsipeptides; Dioxoles; Disulfides; Ethers, Cyclic; Humans; Macrolides; Marine Biology; Neoplasms; Tetrahydroisoquinolines; Trabectedin; Tyrosine | 2008 |
Tyrosine phosphorylation: thirty years and counting.
Topics: Animals; Evolution, Molecular; Humans; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2009 |
New concepts in phospholipase D signaling in inflammation and cancer.
Topics: Chemotaxis; Gene Expression; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Neoplasms; Phospholipase D; Phosphorylation; Protein Serine-Threonine Kinases; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Tyrosine | 2010 |
Histone tyrosine phosphorylation comes of age.
Topics: Apoptosis; Chromatin; DNA Damage; DNA Repair; Genomic Instability; Histones; Humans; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Tyrosine; Ubiquitination | 2011 |
Inside the human cancer tyrosine phosphatome.
Topics: Animals; Humans; Neoplasms; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2011 |
Metabolic positron emission tomography imaging in cancer detection and therapy response.
Topics: Choline; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2011 |
Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases control.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms; S Phase; STAT3 Transcription Factor; Tyrosine | 2012 |
Concomitant tumor resistance.
Topics: Animals; Cell Proliferation; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Tumor Burden; Tyrosine | 2012 |
CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Topics: Amino Acid Sequence; Animals; Antigen Presentation; Antigens, CD1; Antigens, CD1d; Autoimmune Diseases; Bacterial Infections; Cytokines; Glycolipids; Humans; Infections; Killer Cells, Natural; Mice; Models, Immunological; Molecular Sequence Data; Neoplasms; T-Lymphocyte Subsets; Tyrosine; Virus Diseases | 2003 |
The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival.
Topics: Animals; Apoptosis; Cell Division; Cell Survival; Humans; Mice; Mice, Knockout; Neoplasms; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Tumor Suppressor Proteins; Tyrosine | 2004 |
New and old functions of STAT3: a pivotal target for individualized treatment of cancer.
Topics: Animals; Cell Cycle; Cell Survival; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Tyrosine | 2005 |
[Nitric oxide and its related compounds].
Topics: Asthma; Biomarkers; Carbon Monoxide; Chromatography, Gas; Chromatography, High Pressure Liquid; Clinical Enzyme Tests; Enzyme-Linked Immunosorbent Assay; Guanine; Infections; Neoplasms; Nitric Oxide; Pulmonary Disease, Chronic Obstructive; Reference Values; Sepsis; Tyrosine | 2005 |
Balancing cell adhesion and Wnt signaling, the key role of beta-catenin.
Topics: Amino Acid Sequence; Animals; beta Catenin; Cell Adhesion; Humans; Models, Biological; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Phosphorylation; Proto-Oncogenes; Sequence Homology, Amino Acid; Signal Transduction; Transcription Factors; Transcription, Genetic; Tyrosine; Wnt Proteins | 2006 |
Angiogenesis: the VE-cadherin switch.
Topics: Antigens, CD; Atherosclerosis; Cadherins; Capillary Permeability; Cell Cycle; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Protein-tyrosine phosphatases and cancer.
Topics: Animals; ErbB Receptors; Humans; Neoplasms; Phosphorylation; Protein Tyrosine Phosphatases; Tyrosine | 2006 |
Protein tyrosine phosphatases: from genes, to function, to disease.
Topics: Binding Sites; Gene Expression Regulation; Humans; Ligands; Models, Biological; Neoplasms; Oxidation-Reduction; Protein Tyrosine Phosphatases; Signal Transduction; Structure-Activity Relationship; Tumor Suppressor Proteins; Tyrosine | 2006 |
Congenital and inheritable diseases associated with tumors and generalized malignancies--an imaging approach.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Basal Cell Nevus Syndrome; Beckwith-Wiedemann Syndrome; Child; Child, Preschool; Chondroma; Colonic Neoplasms; Down Syndrome; Female; Humans; Intestinal Polyps; Iris; Male; Multiple Endocrine Neoplasia; Neoplasms; Neurofibromatosis 1; Nevus, Pigmented; Tuberous Sclerosis; Tyrosine; von Hippel-Lindau Disease | 1983 |
5-Methylcytosine depletion during tumour development: an extension of the miscoding concept.
Topics: 5-Methylcytosine; Alkylation; Amino Acid Metabolism, Inborn Errors; Animals; Carcinogens; Cell Transformation, Neoplastic; Choline Deficiency; Cytosine; DNA; DNA Repair; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Models, Genetic; Neoplasms; Oncogenes; Rats; Tyrosine; Vitamin B 6 Deficiency | 1983 |
[Oncogenes. 1].
Topics: Animals; Base Sequence; Cell Transformation, Neoplastic; Cell Transformation, Viral; Chromosome Mapping; Chromosomes, Human; DNA, Viral; Gene Expression Regulation; Humans; Neoplasms; Oncogene Protein pp60(v-src); Oncogenes; Phosphorylation; Protein Kinases; Retroviridae; Tyrosine; Viral Proteins | 1984 |
Bacterial metabolism and human carcinogenesis.
Topics: Bacteria; Bile Acids and Salts; Biliary Tract Neoplasms; Cholesterol; Female; Gastrointestinal Neoplasms; Humans; Neoplasms; Nitrosamines; Nitroso Compounds; Pancreatic Neoplasms; Phenols; Schistosomiasis; Tryptophan; Tyrosine; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1980 |
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Topics: Amino Acids; Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphoma; Methionine; Methyltyrosines; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tyrosine | 2001 |
Therapeutic potential of ABX-EGF: a fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; ErbB Receptors; Humans; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Panitumumab; Phosphorylation; Prognosis; Signal Transduction; Transplantation, Heterologous; Tyrosine; Up-Regulation | 2002 |
The role of cholesteryl 14-methylhexadecanoate in gene expression and its significance for cancer.
Topics: Acyltransferases; Amino Acyl-tRNA Synthetases; Animals; Carcinogens; Cholesterol; Fatty Acids; Genes; Liver; Neoplasms; Phospholipids; Protein Biosynthesis; Rats; Ribosomes; RNA, Transfer; Subcellular Fractions; Transcription, Genetic; Transfer RNA Aminoacylation; Triglycerides; Tyrosine | 1975 |
The undercoat of adherens junctions: a key specialized structure in organogenesis and carcinogenesis.
Topics: Animals; Cell Adhesion Molecules; Intercellular Junctions; Morphogenesis; Neoplasms; Phosphorylation; Tyrosine | 1990 |
The cytoskeleton in cancer cells.
Topics: Actins; Animals; Cell Adhesion; Cell Transformation, Neoplastic; Cytoskeleton; DNA; Fibronectins; Humans; Microtubule Proteins; Microtubules; Mutation; Neoplasms; Oncogenes; Phenotype; Phosphorylation; Tropomyosin; Tyrosine | 1985 |
Antigen expression by human trophoblast and tumour cells: models for gene regulation?
Topics: Alkaline Phosphatase; Antibodies, Monoclonal; Antigens, Surface; Female; Gene Expression Regulation; GPI-Linked Proteins; Humans; Immunity, Maternally-Acquired; Isoenzymes; Models, Biological; Neoplasms; Oncogenes; Phosphorylation; Pregnancy; Trophoblasts; Tyrosine | 1985 |
Aspects of amino acid and protein metabolism in cancer-bearing states.
Topics: Adenosine Triphosphate; Adult; Amino Acids; Amino Acids, Branched-Chain; Animals; Body Weight; Brain; Carcinoma 256, Walker; Clinical Trials as Topic; Humans; Leucine; Liver; Muscles; Neoplasms; Nutrition Disorders; Parenteral Nutrition, Total; Proteins; Rats; Tryptophan; Tyrosine; Valine | 1985 |
4 trial(s) available for tyrosine and Benign Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Genistein; Glycine max; Humans; Isoflavones; Male; Middle Aged; Neoplasms; Phosphorylation; Tyrosine | 2003 |
PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2005 |
Aspects of amino acid and protein metabolism in cancer-bearing states.
Topics: Adenosine Triphosphate; Adult; Amino Acids; Amino Acids, Branched-Chain; Animals; Body Weight; Brain; Carcinoma 256, Walker; Clinical Trials as Topic; Humans; Leucine; Liver; Muscles; Neoplasms; Nutrition Disorders; Parenteral Nutrition, Total; Proteins; Rats; Tryptophan; Tyrosine; Valine | 1985 |
181 other study(ies) available for tyrosine and Benign Neoplasms
| Article | Year |
|---|---|
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines.
Topics: Amines; Amino Acids; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Conserved Sequence; Enzyme Activation; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Molecular Structure; Neoplasms; Sequence Alignment; Structure-Activity Relationship | 2008 |
A tribute to Eddy Fischer (April 6, 1920-August 27, 2021): Passionate biochemist and mentor.
Topics: Allosteric Regulation; Biochemistry; Humans; Mentors; Neoplasms; Phosphorylation; Tyrosine | 2022 |
The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cytoskeletal Proteins; Humans; Mice; Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-cbl; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine; Ubiquitin-Protein Ligases | 2022 |
Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor.
Topics: Animals; Disease Progression; Immune Checkpoint Inhibitors; Mice; Neoplasms; Tyrosine | 2022 |
EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Topics: Epidermal Growth Factor; ErbB Receptors; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Phosphorylation; Phosphotyrosine; Pyruvate Kinase; STAT5 Transcription Factor; Tyrosine | 2022 |
The Significance of Cell Surface N-Glycosylation for Internalization and Potency of Cytotoxic Conjugates Targeting Receptor Tyrosine Kinases.
Topics: Antineoplastic Agents; Cell Line, Tumor; Galectins; Glycosylation; Humans; Neoplasms; Tyrosine | 2022 |
A pan-cancer analysis of the oncogenic role of dual-specificity tyrosine (Y)-phosphorylation- regulated kinase 2 (DYRK2) in human tumors.
Topics: Carcinogenesis; Humans; Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Tumor Microenvironment; Tyrosine | 2022 |
Co-expression of receptor tyrosine kinases and CD8 T-lymphocyte genes is associated with distinct prognoses, immune cell infiltration patterns and immunogenicity in cancers.
Topics: Biomarkers, Tumor; CD8-Positive T-Lymphocytes; Humans; Immunotherapy; Neoplasms; Prognosis; Tumor Microenvironment; Tyrosine | 2023 |
Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state.
Topics: Adenosine Triphosphate; Humans; Mutation; Neoplasms; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Tyrosine | 2023 |
Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database.
Topics: Humans; Neoplasms; Proteome; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2023 |
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203.
Topics: Benzoxazoles; Biological Transport; Blood-Brain Barrier; Brain; Humans; Large Neutral Amino Acid-Transporter 1; Neoplasms; Tyrosine | 2023 |
Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy.
Topics: Cell Proliferation; Drug Delivery Systems; ErbB Receptors; Humans; Neoplasms; Peptides; Signal Transduction; Tyrosine | 2024 |
Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk.
Topics: Humans; Mutation; Neoplasms; Phosphorylation; Tyrosine | 2023 |
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.
Topics: Animals; B7-H1 Antigen; Benzofurans; Carboxylic Acids; Immunotherapy; Mice; Neoplasms; Organic Chemicals; Programmed Cell Death 1 Receptor; Protein Tyrosine Phosphatases; Receptors, Antigen, T-Cell; Tyrosine | 2023 |
Promoting the activity of a receptor tyrosine phosphatase with a novel pH-responsive transmembrane agonist inhibits cancer-associated phenotypes.
Topics: ErbB Receptors; Humans; Hydrogen-Ion Concentration; Neoplasms; Phenotype; Phosphorylation; Protein Tyrosine Phosphatases; Tumor Microenvironment; Tyrosine | 2023 |
Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
Topics: Alzheimer Disease; Humans; Molecular Docking Simulation; Neoplasms; Phytochemicals; Proto-Oncogene Proteins c-fyn; Tyrosine | 2023 |
Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.
Topics: Amino Acid Substitution; Arginine; Calmodulin-Binding Proteins; Carcinogenesis; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Neoplasms; Nerve Tissue Proteins; Protein Kinase Inhibitors; Protein Phosphatase 2; Recombinant Proteins; Transfection; Tyrosine; Xenograft Model Antitumor Assays | 2020 |
Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB
Topics: Amino Acid Transport Systems; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Humans; Irinotecan; Large Neutral Amino Acid-Transporter 1; Liposomes; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Tyrosine | 2019 |
Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation.
Topics: Animals; Biological Transport; Cold Temperature; Ganglia, Spinal; HEK293 Cells; Humans; Inflammation; Neoplasms; Neurons, Afferent; Pain; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Rats; src-Family Kinases; TRPM Cation Channels; Tyrosine | 2020 |
Structural basis for the activation of PLC-γ isozymes by phosphorylation and cancer-associated mutations.
Topics: Crystallography, X-Ray; Enzyme Activation; Humans; Isoenzymes; Mutation; Neoplasms; Phospholipase C gamma; Phosphorylation; Protein Conformation; Protein Domains; Tyrosine | 2019 |
The Rectus Sheath Block (RSB) Analgesia Following Laparotomy Could Affect Malonidialdehyde (MDA) Concentrations in Benign Disease and Cancer.
Topics: Analgesia; Catalase; Female; Humans; Laparotomy; Male; Malondialdehyde; Middle Aged; Neoplasms; Nerve Block; Tyrosine | 2020 |
Cationic Pillar[6]arene Induces Cell Apoptosis by Inhibiting Protein Tyrosine Phosphorylation Via Host-Guest Recognition.
Topics: Antineoplastic Agents; Apoptosis; Cations; Drug Carriers; Hep G2 Cells; Humans; Nanostructures; Neoplasms; Phosphorus; Phosphorylation; Quaternary Ammonium Compounds; Tyrosine | 2020 |
Phosphorylation of PUF-A/PUM3 on Y259 modulates PUF-A stability and cell proliferation.
Topics: Atlases as Topic; Carcinogenesis; Cell Movement; Cell Nucleolus; Cell Proliferation; CRISPR-Cas Systems; Databases, Genetic; Female; Gene Deletion; HeLa Cells; Humans; Minor Histocompatibility Antigens; Mutation; Neoplasms; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Stability; Survival Analysis; Tyrosine | 2021 |
A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer.
Topics: Animals; Antibodies, Bispecific; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Interleukin-2; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Neoplasms; Phosphorylation; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Tyrosine; Xenograft Model Antitumor Assays | 2017 |
KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase.
Topics: Acetyl Coenzyme A; Acyl Coenzyme A; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Crystallography, X-Ray; Female; Gene Expression Regulation; Histone Acetyltransferases; Histones; Humans; Ketoglutarate Dehydrogenase Complex; Lysine; Mice; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms; Protein Binding; Protein Domains; Transcription Initiation Site; Tyrosine | 2017 |
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell Polarity; Humans; Macrophages; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase 7; Neoplasms; Phosphorylation; Receptors, Cell Surface; STAT3 Transcription Factor; Tyrosine; Xenograft Model Antitumor Assays | 2018 |
Curcumin Ag nanoconjugates for improved therapeutic effects in cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Curcumin; Drug Screening Assays, Antitumor; Humans; Metal Nanoparticles; Nanoconjugates; Neoplasms; Tyrosine | 2018 |
Multistimuli-Responsive Amphiphilic Poly(ester-urethane) Nanoassemblies Based on l-Tyrosine for Intracellular Drug Delivery to Cancer Cells.
Topics: Animals; Camptothecin; Doxorubicin; Drug Delivery Systems; Endocytosis; HeLa Cells; Humans; Lysosomes; MCF-7 Cells; Mice; Nanoparticles; Neoplasms; Polyesters; Polyurethanes; Tyrosine | 2018 |
Development of novel affinity reagents for detecting protein tyrosine phosphorylation based on superbinder SH2 domain in tumor cells.
Topics: Arginine; Cell Line, Tumor; Fluorescent Antibody Technique; Green Fluorescent Proteins; Humans; Immunoblotting; Microscopy, Fluorescence; Neoplasms; Optical Imaging; Phosphorylation; src Homology Domains; src-Family Kinases; Tyrosine | 2018 |
Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment.
Topics: Antigens, Neoplasm; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Neoplasm Proteins; Neoplasms; Phosphorylation; RNA, Small Interfering; Signal Transduction; STAT1 Transcription Factor; Tumor Escape; Tumor Microenvironment; Tyrosine; Up-Regulation | 2018 |
ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.
Topics: Anaplastic Lymphoma Kinase; Animals; Cell Line; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Phosphorylation; Smad4 Protein; Transforming Growth Factor beta; Transplantation, Heterologous; Tyrosine | 2019 |
A cancer-associated point mutation disables the steric gate of human PrimPol.
Topics: Animals; Cell Cycle; Cell Line; Computer Simulation; DNA Primase; DNA-Directed DNA Polymerase; Drug Resistance; Histidine; Humans; Hydroxyurea; Mice; Models, Molecular; Multifunctional Enzymes; Neoplasms; Nucleotides; Point Mutation; Tyrosine | 2019 |
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Cardiotoxicity; Cell Communication; Cell-Derived Microparticles; Cells, Cultured; Endothelial Cells; Endothelin-1; Female; Humans; Male; Middle Aged; Neoplasms; Nitric Oxide; Reactive Oxygen Species; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor A | 2019 |
ALK-mediated Tyr95 phosphorylation of Smad4 impairs its transcription activity and the tumor suppressive activity of TGF-β.
Topics: Anaplastic Lymphoma Kinase; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Phosphorylation; Protein Binding; Smad4 Protein; Transcriptional Activation; Transforming Growth Factor beta; Tumor Suppressor Proteins; Tyrosine | 2019 |
Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; HEK293 Cells; Humans; Kinetics; Mice; Mice, Nude; Models, Molecular; NADP; Neoplasms; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Phosphorylation; Radiation, Ionizing; Reactive Oxygen Species; Ribosemonophosphates; Tyrosine; Up-Regulation | 2019 |
Psammaplysin F increases the efficacy of bortezomib and sorafenib through regulation of stress granule formation.
Topics: Animals; Bortezomib; Chlorocebus aethiops; Cytoplasmic Granules; Drug Resistance, Neoplasm; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Sorafenib; Spiro Compounds; Tyrosine; Vero Cells | 2019 |
Investigation of the role of transporters on the hepatic elimination of an LAT1 selective inhibitor JPH203.
Topics: Animals; Antineoplastic Agents; Benzoxazoles; Bile; HEK293 Cells; Hepatocytes; Humans; Large Neutral Amino Acid-Transporter 1; Male; Neoplasms; Rats; Rats, Sprague-Dawley; Tyrosine | 2013 |
Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lysine; Male; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; Neoplasms; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide); Pyruvate Dehydrogenase (Lipoamide)-Phosphatase; Sirtuin 3; Tyrosine | 2014 |
Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Line, Tumor; Epidermal Growth Factor; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; STAT3 Transcription Factor; Tyrosine; Up-Regulation | 2014 |
Bioactive tyrosine-derived cytochalasins from fungus Eutypella sp. D-1.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytochalasins; Humans; MCF-7 Cells; Neoplasms; Tyrosine; Xylariales | 2014 |
Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Base Sequence; Cell Division; Cell Line, Tumor; DNA Primers; Humans; Lactic Acid; Molecular Sequence Data; Neoplasms; Oxygen Consumption; Phosphorylation; Pyruvate Dehydrogenase (Lipoamide)-Phosphatase; Receptor, Fibroblast Growth Factor, Type 1; Sequence Homology, Amino Acid; Tyrosine | 2014 |
[Plasma amino acid profiling of "same symptom for different disease" in Uyghur medicine based on high-performance liquid chromatography].
Topics: Amino Acids; Arginine; Aspartic Acid; Chromatography, High Pressure Liquid; Cystine; Humans; Isoleucine; Leucine; Medicine, Chinese Traditional; Neoplasms; Serine; Tyrosine; Valine | 2014 |
Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity.
Topics: Apoptosis; Catalysis; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Jurkat Cells; Neoplasms; Nitrogen; Oxidation-Reduction; Phosphorylation; Protein Phosphatase 2; Proto-Oncogene Proteins c-bcl-2; Serine; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2014 |
New water-soluble copper (II) complexes including 4,7-dimethyl-1,10-phenanthroline and L-tyrosine: synthesis, characterization, DNA interactions and cytotoxicities.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Copper; Crystallography, X-Ray; DNA; DNA Cleavage; Humans; Intercalating Agents; Models, Molecular; Neoplasms; Phenanthrolines; Tyrosine | 2015 |
Ectoenzyme switches the surface of magnetic nanoparticles for selective binding of cancer cells.
Topics: Alkaline Phosphatase; Cells, Cultured; GPI-Linked Proteins; HeLa Cells; Humans; Isoenzymes; Magnetite Nanoparticles; Nanostructures; Neoplasms; Phosphorylation; Stromal Cells; Surface Properties; Tyrosine | 2015 |
Thermoresponsive polymer system based on poly(N-vinylcaprolactam) intended for local radiotherapy applications.
Topics: Biocompatible Materials; Brachytherapy; Caprolactam; Humans; Iodine Radioisotopes; Materials Testing; Methacrylates; Neoplasms; Polymers; Solubility; Temperature; Tyrosine; Water | 2015 |
Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis.
Topics: Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Progression; DNA; DNA Mismatch Repair; ErbB Receptors; Genome; Genome, Human; HeLa Cells; Humans; Microscopy, Fluorescence; Models, Molecular; Mutation; Neoplasms; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Binding; Sequence Analysis, DNA; Tyrosine | 2015 |
Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Topics: Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Discoidin Domain Receptor 1; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Humans; Immunoprecipitation; Mice; Microscopy, Confocal; Neoplasms; Phosphorylation; Protein Transport; Real-Time Polymerase Chain Reaction; Receptor Protein-Tyrosine Kinases; Receptor, IGF Type 1; Receptors, Somatomedin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tyrosine | 2015 |
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2015 |
Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation.
Topics: Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; Glycolysis; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Phosphorylation; Pyruvate Dehydrogenase Complex; Reactive Oxygen Species; src-Family Kinases; Tyrosine | 2016 |
Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; MAP Kinase Signaling System; Mice; Microtubule-Associated Proteins; Neoplasms; NIH 3T3 Cells; Oncogene Proteins, Fusion; Phosphorylation; Protein Domains; Proteomics; Receptor, Fibroblast Growth Factor, Type 3; Tandem Mass Spectrometry; Tyrosine | 2016 |
Evaluation of toxicity on epithelial and tumor cells of biaryl dipeptide tyrosines.
Topics: Cell Death; Cell Proliferation; Cells, Cultured; Dipeptides; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Tyrosine | 2016 |
Stabilizing the cold plasma-stimulated medium by regulating medium's composition.
Topics: Antineoplastic Agents; Culture Media; Cysteine; Free Radicals; Freezing; Helium; Humans; Hydrogen Peroxide; Methionine; Neoplasms; Radiation; Tyrosine | 2016 |
SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Topics: Cell Membrane; Enzyme Activation; Gene Expression; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methylation; Neoplasms; Phosphorylation; Pleckstrin Homology Domains; Proto-Oncogene Proteins c-akt; Signal Transduction; Tyrosine | 2016 |
Phosphorylation of H2A.X
Topics: Amino Acid Sequence; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Comet Assay; Disease Progression; DNA Breaks, Double-Stranded; DNA Repair; Hep G2 Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Mutation; Neoplasms; Nuclear Proteins; Phosphorylation; Protein Tyrosine Phosphatases; RNA Interference; Sequence Homology, Amino Acid; Tyrosine | 2016 |
c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Glucose; Glucose-6-Phosphate; Glycolysis; Heterografts; Hexokinase; Humans; Kinetics; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasms; Phosphorylation; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Tyrosine | 2017 |
Molecular dynamics simulation reveals how phosphorylation of tyrosine 26 of phosphoglycerate mutase 1 upregulates glycolysis and promotes tumor growth.
Topics: 2,3-Diphosphoglycerate; Algorithms; Amino Acid Sequence; Glyceric Acids; Glycolysis; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Neoplasms; Phosphoglycerate Mutase; Phosphorylation; Principal Component Analysis; Protein Binding; Sequence Homology, Amino Acid; Static Electricity; Substrate Specificity; Thermodynamics; Tyrosine | 2017 |
Studies in protein metabolism with compounds labeled with radioactive carbon; metabolism of dl-tyrosine in the normal and tumor-bearing rat.
Topics: Amino Acids; Animals; Carbon; Dietary Proteins; Neoplasms; Proteins; Rats; Tyrosine | 1948 |
Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1.
Topics: Animals; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p27; Embryonic Stem Cells; Humans; Mice; Mice, Knockout; Neoplasms; Phosphorylation; Predictive Value of Tests; Prognosis; ras Proteins; STAT1 Transcription Factor; Transcription, Genetic; Tyrosine | 2008 |
Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Catalysis; Hemodynamics; Interleukin-2; Lung; Lymph; Malondialdehyde; Neoplasms; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Peroxynitrous Acid; Pulmonary Gas Exchange; Recombinant Proteins; Sheep; Tyrosine | 2008 |
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.
Topics: Amino Acid Sequence; Drug Resistance, Neoplasm; HeLa Cells; Humans; Kidney; Molecular Sequence Data; Mutagenesis, Site-Directed; Neoplasms; Piperidines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-ret; Quinazolines; Structure-Activity Relationship; Tyrosine | 2009 |
SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.
Topics: Adherens Junctions; Animals; Calpain; Cell Line; Cell Movement; Cloning, Molecular; Dogs; Extracellular Signal-Regulated MAP Kinases; GRB2 Adaptor Protein; Guanine Nucleotide Exchange Factors; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Mutation; Neoplasm Invasiveness; Neoplasms; Oncogene Protein pp60(v-src); Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-yes; Proto-Oncogene Proteins pp60(c-src); Recombinant Fusion Proteins; SOS1 Protein; src Homology Domains; src-Family Kinases; T-Lymphoma Invasion and Metastasis-inducing Protein 1; Time Factors; Transfection; Tyrosine | 2009 |
Evaluation of O-[(18)F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography.
Topics: Animals; Biological Transport; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Rats; Rats, Inbred F344; Staining and Labeling; Stereoisomerism; Tyrosine | 2009 |
Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout.
Topics: Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; ErbB Receptors; Gene Expression Profiling; Humans; Kinetics; Mice; Mice, Nude; Neoplasms; Phosphorylation; Phosphotyrosine; Protein Array Analysis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Transplantation, Heterologous; Tyrosine | 2009 |
Synthesis and evaluation of novel F-18 labeled fluoroarylvaline derivatives: potential PET imaging agents for tumor detection.
Topics: Animals; Benzamides; Butyrates; Cell Line, Tumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mice; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine | 2009 |
Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Positron-Emission Tomography; Rats; Thymidine Phosphorylase; Tissue Distribution; Tyrosine | 2009 |
New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: simple, fast, and high yielding automated synthesis.
Topics: Automation; Chromatography, Gas; Neoplasms; Radiopharmaceuticals; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tyrosine | 2009 |
PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect.
Topics: Animals; Cell Proliferation; Citric Acid Cycle; Glutamine; Glycolysis; Humans; Models, Biological; Neoplasms; Phosphorylation; Protein Multimerization; Pyruvate Kinase; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Tyrosine | 2009 |
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Fructosediphosphates; Glucose; Glycolysis; Humans; Immunoblotting; K562 Cells; Male; Mice; Mice, Nude; Mutation; Neoplasms; Neoplasms, Experimental; Oxygen Consumption; Phosphorylation; Proteomics; Pyruvate Kinase; Receptor, Fibroblast Growth Factor, Type 1; Transplantation, Heterologous; Tumor Burden; Tyrosine | 2009 |
Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.
Topics: Acetazolamide; Antigens, Neoplasm; Apoptosis; Blotting, Western; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Carbonic Anhydrase IX; Carbonic Anhydrases; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ceramides; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Neoplasms; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; Tyrosine | 2010 |
Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential.
Topics: Cell Line, Tumor; Enzyme Activation; Humans; Neoplasm Invasiveness; Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Serine; Tyrosine | 2011 |
Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence.
Topics: Actins; Blotting, Western; Cell Line, Tumor; Cell Movement; Cortactin; Epidermal Growth Factor; Green Fluorescent Proteins; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Dynamics Simulation; Neoplasms; Phosphorylation; Protein Conformation; Pseudopodia; RNA Interference; Serine; Tyrosine; Wiskott-Aldrich Syndrome Protein | 2010 |
c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.
Topics: Animals; Cell Division; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phospholipase C gamma; Phosphorylation; Proto-Oncogene Proteins c-cbl; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.
Topics: Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Growth Processes; Cell Line, Tumor; Drug Resistance, Neoplasm; Epidermal Growth Factor; Gene Knockdown Techniques; HCT116 Cells; Heat-Shock Proteins; HEK293 Cells; HSP27 Heat-Shock Proteins; Humans; Insulin; Lectins, C-Type; Mitogen-Activated Protein Kinases; Molecular Chaperones; Neoplasms; Pancreatitis-Associated Proteins; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine; Up-Regulation | 2012 |
A drug resistance screen using a selective MET inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients.
Topics: Amino Acid Substitution; Aminopyridines; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Transformed; Cell Line, Tumor; Crystallography, X-Ray; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Mice; Models, Molecular; Mutagenesis; Mutation, Missense; Neoplasms; Point Mutation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-met; Pyrazoles; Quinolines; Receptors, Growth Factor; Tyrosine | 2011 |
Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors.
Topics: Antineoplastic Agents; Cell Survival; Drug Design; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Neoplasms; Repressor Proteins; Structure-Activity Relationship; Tyrosine | 2011 |
Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Glycolysis; Homeostasis; Humans; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; Mice; Mice, Nude; Mitochondria; NAD; Neoplasms; Oxidation-Reduction; Phosphorylation; Receptor, Fibroblast Growth Factor, Type 1; Tyrosine | 2011 |
Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants.
Topics: Anaplastic Lymphoma Kinase; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Fibroblasts; Humans; Mice; Neoplasms; Phosphorylation; Point Mutation; Receptor Protein-Tyrosine Kinases; Tyrosine | 2013 |
Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Carriers; Female; Glycerol; Humans; Maximum Tolerated Dose; Mice; Mice, Nude; Nanospheres; Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Tyrosine; Xenograft Model Antitumor Assays | 2012 |
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.
Topics: Animals; Female; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Transplantation, Heterologous; Tyrosine | 2011 |
Fer kinase regulates cell migration through α-dystroglycan glycosylation.
Topics: Basement Membrane; Cell Line, Tumor; Cell Movement; Down-Regulation; Dystroglycans; Gene Knockdown Techniques; Glycosylation; Humans; Lamins; Mannosyltransferases; N-Acetylglucosaminyltransferases; Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; RNA, Small Interfering; STAT3 Transcription Factor; Transcription, Genetic; Tyrosine | 2012 |
Microfluidic technology: an economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET).
Topics: Animals; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Half-Life; Isotope Labeling; Mice; Mice, Inbred BALB C; Microfluidics; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine | 2012 |
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biological Transport; Cell Line; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Mice; Neoplasms; Positron-Emission Tomography; Tyrosine; Up-Regulation | 2012 |
Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3.
Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; HEK293 Cells; HeLa Cells; Hep G2 Cells; HSP90 Heat-Shock Proteins; Humans; Luteolin; Mice; Neoplasms; Phosphorylation; Protein Binding; Proteolysis; Signal Transduction; STAT3 Transcription Factor; Tyrosine; Xenograft Model Antitumor Assays | 2012 |
Visualizing and manipulating focal adhesion kinase regulation in live cells.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Movement; Chickens; Fluorescence Resonance Energy Transfer; Fluorometry; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hydrogen-Ion Concentration; Insecta; Models, Statistical; Neoplasms; Phosphorylation; Protein Conformation; Protein Interaction Mapping; Tyrosine | 2013 |
Tyrosine phosphorylation in cell signaling and disease.
Topics: Humans; Neoplasms; Phosphorylation; Protein Kinases; Signal Transduction; Tyrosine | 2002 |
Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Topics: DNA-Binding Proteins; Epidermal Growth Factor; ErbB Receptors; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; ras Proteins; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Tyrosine | 2003 |
Fully automated synthesis of O-(3-[18F]fluoropropyl)-L-tyrosine by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin.
Topics: Anion Exchange Resins; Isotope Labeling; Neoplasms; Pyridinium Compounds; Quality Control; Radiopharmaceuticals; Robotics; Tomography, Emission-Computed; Tyrosine | 2003 |
Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.
Topics: Antineoplastic Agents; ErbB Receptors; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Mitogen-Activated Protein Kinases; Neoplasms; Quinazolines; Signal Transduction; Skin; Tyrosine; Up-Regulation | 2003 |
Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Ligands; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Mouth Neoplasms; Neoplasms; Paclitaxel; Phosphorylation; Propidium; Pyrimidines; Pyrroles; Tongue; Tongue Neoplasms; Tyrosine | 2003 |
Mixed tumor of parotid gland with tyrosine crystals in the matrix; report of case.
Topics: Adenoma, Pleomorphic; Neoplasms; Parotid Gland; Parotid Neoplasms; Salivary Gland Neoplasms; Tyrosine | 1953 |
[Studies on the tyrosine levels of non-heat precipitated, protein-like materials of human serum and gastric juice in cancer patients].
Topics: Blood; Gastric Juice; Hot Temperature; Humans; Neoplasms; Tyrosine | 1954 |
Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256.
Topics: Animals; Biological Phenomena; Carcinoma 256, Walker; Ketoglutaric Acids; Liver; Neoplasms; Physiological Phenomena; Transaminases; Tyrosine | 1960 |
[Effect of certain components of nucleic acids and of their conversion on the inclusion of glycine1-C14 and tyrosine-1-C14 into proteins of normal and tumor cells].
Topics: Biochemical Phenomena; Neoplasms; Nucleic Acids; Proteins; Tyrosine | 1961 |
[My method of tumor therapy].
Topics: Cholesterol; Humans; Lecithins; Neoplasms; Phosphatidylcholines; Tyrosine | 1960 |
The tyrosine and tryptophan content of blood serum in malignant disease.
Topics: Hematologic Diseases; Humans; Neoplasms; Serum; Syndrome; Tryptophan; Tyrosine | 1960 |
[Phenylalanine hydroxylase activity in hepatomas and livers of normal and tumor-bearing animals].
Topics: Animals; Carcinoma, Hepatocellular; Enzymes; Liver; Liver Neoplasms; Neoplasms; Phenylalanine; Phenylalanine Hydroxylase; Tyrosine | 1961 |
[Autoradiographic studies on protein and melanin metabolism in different cell types in melanoma in mice (Harding-Passey type)].
Topics: Animals; Autoradiography; Dihydroxyphenylalanine; Melanins; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Proline; Proteins; Tyrosine | 1962 |
[Content and distribution of tyrosine in cancerous tumors (histochemical study)].
Topics: Humans; Neoplasms; Tyrosine | 1962 |
Effects of amino acids, analogs, and certain other agents in relation to tyrosine transport in sarcoma 37 ascites cells.
Topics: Amino Acids; Animals; Ascites; Azides; Cyanides; Iodoacetates; Malonates; Neoplasms; Nitrophenols; Organic Chemicals; Phenylalanine; Sarcoma; Sarcoma 37; Sarcoma, Experimental; Tyrosine | 1962 |
[BIOCHEMICAL STUDIES ON THE METABOLISM OF THE TUMOR BEARING ANIMALS. II. RESEARCHES FOR THE AMINO ACIDS IN THE URINE OF THE RATS FED ON THE DAB-RICE].
Topics: Amino Acids; Chromatography; Kynurenine; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Rats; Renal Aminoacidurias; Research; Toxicology; Tyrosine; Urine | 1963 |
[CONTRIBUTION TO THE STUDY OF RIBONUCLEOPROTEINS OF NORMAL AND NEOPLASTIC TISSUES].
Topics: Alanine; Arginine; Aspartic Acid; Chemical Phenomena; Chemistry; Glutamates; Glycine; Isoleucine; Leucine; Liver; Lysine; Mice; Neoplasm Proteins; Neoplasms; Nucleoproteins; Phenylalanine; Rats; Research; Ribonucleoproteins; RNA; RNA, Neoplasm; Serine; Threonine; Tyrosine; Valine | 1963 |
HOST-TUMOUR RELATIONSHIP. X.
Topics: Blood Proteins; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Glycoproteins; Hepatitis; Hexosamines; Liver Glycogen; Neoplasms; Neuraminic Acids; Rats; Research; Toxicology; Turpentine; Tyrosine | 1964 |
HOST-TUMOUR RELATIONSHIP. XI. THE ROLE OF THE LIVER IN THE SYNTHESIS OF SERUM GLYCOPROTEINS DURING THE COURSE OF GROWTH OF JENSEN'S SARCOMA.
Topics: Blood Proteins; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Glycoproteins; Hepatitis; Hexosamines; Neoplasms; Neuraminic Acids; Polarography; Rats; Research; Sarcoma; Sarcoma, Experimental; Toxicology; Tyrosine | 1964 |
FREE AMINO ACIDS OF HUMAN BREAST CANCER.
Topics: Amino Acids; Asparagine; Aspartic Acid; Breast Neoplasms; Chromatography; Citrulline; Glutamates; Glutamine; Glycine; Humans; Isoleucine; Leucine; Liver Neoplasms; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Proline; Research; Serine; Threonine; Tyrosine | 1964 |
[DIFFERENTIAL DIAGNOSIS OF MALIGNANT MELANOMA].
Topics: Biopsy; Diagnosis, Differential; Granuloma; Hemangioma; Histiocytoma, Benign Fibrous; Histocytochemistry; Humans; Leiomyoma; Melanoma; Neoplasms; Tyrosine; Tyrosine Decarboxylase; Urine | 1964 |
IODOTYROSINE-LIKE SUBSTANCES IN HUMAN SERUM.
Topics: Blood Chemical Analysis; Chromatography; Geriatrics; Goiter; Hyperthyroidism; Iodine Isotopes; Monoiodotyrosine; Myxedema; Neoplasms; Propylthiouracil; Thiourea; Thyronines; Thyroxine; Tyrosine | 1964 |
THE VALUE OF SEROMUCOID ESTIMATION IN THE MANAGEMENT OF PROSTATIC DISEASE.
Topics: Acid Phosphatase; Blood Chemical Analysis; Diagnosis, Differential; Humans; Male; Mucoproteins; Neoplasms; Orosomucoid; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Tyrosine | 1964 |
FUNCTIONING FOLLICULAR METASTATIC CARCINOMA OF THE THYROID.
Topics: Carcinoma; Humans; Iodine Isotopes; Neoplasm Metastasis; Neoplasms; Pathology; Pharmacology; Thoracic Neoplasms; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Tyrosine | 1964 |
HYDROXYLATION OF TRYPTOPHAN AND PHENYLALANINE IN NEOPLASTIC MAST CELLS OF THE MOUSE.
Topics: Animals; Hydroxylation; Indoles; Mast Cells; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Phenylalanine; Research; Tryptophan; Tyrosine | 1964 |
STUDIES OF FUNCTIONAL NEURAL TUMORS. VI. BIOCHEMICAL DIAGNOSIS.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Amino Acids; Child; Dihydroxyphenylalanine; Ganglioneuroma; Geriatrics; Head and Neck Neoplasms; Humans; Infant; Mandelic Acids; Metabolism; Neoplasms; Neuroblastoma; Phenylacetates; Pheochromocytoma; Thoracic Neoplasms; Tyrosine | 1964 |
[ON THE ANTINEOPLASTIC ACTIVITY OF O--(N,N--BIS(2-CHLOROETHYL)-P-AMINOPHENYL)-D,-TYROSINE(PHENTYRIN)].
Topics: Antineoplastic Agents; Hematopoiesis; Mice; Neoplasms; Neoplasms, Experimental; Nitrogen Mustard Compounds; Pharmacology; Research; Toxicology; Tyrosine | 1964 |
ACTIVITIES OF VARIOUS AMINOTRANSFERASES IN TUMOR-BEARING RATS.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Alanine Transaminase; Animals; Aspartate Aminotransferases; Dietary Carbohydrates; Fasting; Glucose; Liver; Neoplasms; Neoplasms, Experimental; Pathology; Physiology; Pituitary Gland; Pregnancy; Pregnancy, Animal; Protein Deficiency; Proteins; Rats; Research; Transaminases; Tyrosine | 1964 |
TREATMENT OF LEUKAEMIA BY AMINOACID IMBALANCE.
Topics: Amino Acids; Child; Diet; Diet Therapy; Dietary Proteins; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphocytes; Neoplasms; Phenylalanine; Tyrosine | 1965 |
THE BIOCHEMICAL MECHANISM OF ACTION OF L-PHENYLALANINE MUSTARD. I. DISTRIBUTION OF L-PHENYLALANINE MUSTARD-H3 IN TUMOR-BEARING RATS.
Topics: Animals; Bone Marrow; Carcinoma 256, Walker; Chromatography; DNA; Intestines; Kidney; Liver; Melphalan; Metabolism; Muscles; Mustard Plant; Neoplasms; Pharmacology; Phenylalanine; Plasma; Rats; Research; Spleen; Thymus Gland; Tritium; Tyrosine | 1965 |
Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.
Topics: Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; Cancer Vaccines; CD4-Positive T-Lymphocytes; DNA; DNA, Complementary; Enzyme-Linked Immunosorbent Assay; Ligands; Lymph Nodes; Lymphatic Metastasis; Membrane Glycoproteins; Mice; Mice, Transgenic; Neoplasm Transplantation; Neoplasms; Phosphorylation; Plasmids; Protein-Tyrosine Kinases; Rats; Receptor, ErbB-2; Receptors, Nerve Growth Factor; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor Receptor Superfamily, Member 9; Tyrosine; Vaccines, DNA | 2003 |
The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.
Topics: Animals; Blotting, Western; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cloning, Molecular; Dimerization; Disulfides; DNA, Complementary; Dogs; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Genetic Therapy; Hepatocyte Growth Factor; Humans; Ligands; Models, Genetic; Neoplasms; Phosphorylation; Precipitin Tests; Protein Binding; Protein Biosynthesis; Protein Structure, Tertiary; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2004 |
Radiation dosimetry of O-(3-[18F]fluoropropyl)-L-tyrosine as oncologic PET tracer based on the mice distribution data.
Topics: Animals; Fluorine Radioisotopes; Mice; Neoplasms; Pharmacokinetics; Radiation Dosage; Radiometry; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2004 |
Structure of human PRL-3, the phosphatase associated with cancer metastasis.
Topics: Amino Acid Sequence; Binding Sites; Enzyme Inhibitors; Humans; Immediate-Early Proteins; Ions; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Phosphates; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Protein Tyrosine Phosphatases; Sequence Homology, Amino Acid; Tyrosine; Vanadates | 2004 |
Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chemotherapy, Adjuvant; Chromatography; Cytoskeleton; Electrophoresis, Gel, Two-Dimensional; Heat-Shock Proteins; Humans; Immunoblotting; Ligands; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Phosphoproteins; Phosphorylation; Phosphotyrosine; Signal Transduction; Tyrosine | 2004 |
Tumor-host studies. II. Increased concentration of tagged iodotyrosines in the gastrointestinal tract of rats bearing tumors.
Topics: Animals; Digestive System; Gastrointestinal Tract; Iodine; Iodine Radioisotopes; Monoiodotyrosine; Neoplasms; Rats; Tyrosine | 1950 |
The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice.
Topics: Animals; Anticarcinogenic Agents; Antigens; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspases; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cell Nucleus; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Glutathione; Humans; Isothiocyanates; Male; Membrane Potentials; Mice; Mice, SCID; Microscopy, Fluorescence; Mitochondria; Mitosis; Neoplasm Transplantation; Neoplasms; Oxidative Stress; Pancreatic Neoplasms; Reactive Oxygen Species; Staurosporine; Sulfoxides; Thiocyanates; Time Factors; Tyrosine | 2004 |
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
Topics: Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Chromatography, Liquid; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Mass Spectrometry; Mice; Neoplasms; NIH 3T3 Cells; Peptides; Phosphorylation; Phosphotyrosine; Proteomics; Signal Transduction; Tyrosine | 2005 |
Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids.
Topics: Animals; Carcinoma; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Collagen; Colon; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoprecipitation; Liver; Liver Neoplasms; Male; Microcirculation; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasms; Oligonucleotides; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Time Factors; Transfection; Tyrosine | 2005 |
p53 mediates a default programme of mammary gland involution in the absence of STAT3.
Topics: Adipocytes; Animals; Apoptosis; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Epithelium; Female; Genotype; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mutation; Neoplasms; Phosphorylation; STAT3 Transcription Factor; Time Factors; Trans-Activators; Tumor Suppressor Protein p53; Tyrosine | 2005 |
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
Topics: Animals; Blotting, Western; Cell Adhesion; CSK Tyrosine-Protein Kinase; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glutathione Transferase; Humans; Immunoblotting; Immunoprecipitation; Mutation; Neoplasms; Paxillin; Peptides; Phenotype; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Binding; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Receptor-Like Protein Tyrosine Phosphatases, Class 3; src-Family Kinases; Thyroid Gland; Thyroid Neoplasms; Transfection; Tyrosine | 2005 |
Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase.
Topics: Active Transport, Cell Nucleus; Alternative Splicing; Androstadienes; Animals; beta Catenin; Blotting, Western; Cell Nucleus; Cyclin D1; Cytoplasm; Cytoskeletal Proteins; Enzyme Inhibitors; Gene Silencing; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Mice; Models, Biological; Neoplasms; NIH 3T3 Cells; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-myc; Receptor Protein-Tyrosine Kinases; RNA, Messenger; RNA, Small Interfering; Serine; Trans-Activators; Tyrosine; Wortmannin | 2005 |
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Biological Assay; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Endothelial Cells; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Saponins; Sea Cucumbers; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Animals, Newborn; Astrocytes; Brain; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cells, Cultured; Disease Progression; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Fluorescent Antibody Technique, Indirect; Genetic Vectors; HeLa Cells; Humans; Immunoprecipitation; Microscopy, Fluorescence; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Peptides; Phosphoproteins; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; RNA Interference; RNA-Binding Proteins; Sequence Homology, Amino Acid; Signal Transduction; Tyrosine | 2005 |
Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.
Topics: Aniline Compounds; Animals; Binding, Competitive; Carbon Radioisotopes; Cell Line; DNA; ErbB Receptors; Fluorine Radioisotopes; Humans; Isotope Labeling; Ligands; Mice; Neoplasms; Phosphorylation; Quinazolines; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptor, ErbB-4; Structure-Activity Relationship; Tyrosine | 2005 |
Can the apparent conflicting roles of PKC delta on cell proliferation and survival be reconciled?
Topics: Cell Proliferation; Cell Survival; Humans; Neoplasms; Protein Kinase C-delta; Tumor Suppressor Proteins; Tyrosine | 2006 |
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine | 2006 |
A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9.
Topics: Amino Acid Sequence; Cell Line, Tumor; Epithelium; Galectins; Hepatitis A Virus Cellular Receptor 2; Humans; Membrane Proteins; Molecular Sequence Data; Neoplasms; Organ Specificity; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Virus; src Homology Domains; Tyrosine | 2006 |
Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Topics: Antineoplastic Agents; Azurin; Cell Line, Tumor; Cell Proliferation; Copper; Ephrin-B2; Humans; Models, Molecular; Mutation; Neoplasms; Peptides; Phosphorylation; Protein Structure, Tertiary; Receptor, EphB2; Tyrosine | 2007 |
Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds.
Topics: Alkynes; Amination; Animals; Azides; Carbonic Acid; Catalysis; Cell Line, Tumor; Chromatography, High Pressure Liquid; Copper; Cyclization; Female; Heterocyclic Compounds, 1-Ring; Ketones; Mice; Mice, Nude; Molecular Structure; Neoplasms; Oximes; Oxygen; Peptides; Rats; Tyrosine; Xenograft Model Antitumor Assays | 2007 |
Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.
Topics: Antineoplastic Agents; Biological Products; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Molecular Structure; Neoplasms; Protein Methyltransferases; Spermine; Tyrosine | 2007 |
Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells.
Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Cysteine; HeLa Cells; Humans; Mass Spectrometry; Mice; Molecular Sequence Data; Neoplasms; NIH 3T3 Cells; Oxidation-Reduction; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Reactive Oxygen Species; Tyrosine | 2008 |
Mass spectrometric detection of tyrosine sulfation in human pancreatic trypsinogens, but not in tumor-associated trypsinogen.
Topics: Alkylation; Amino Acid Sequence; Cell Line, Tumor; Humans; Molecular Sequence Data; Neoplasms; Pancreas; Phosphorylation; Spectrometry, Mass, Electrospray Ionization; Sulfates; Trypsinogen; Tyrosine | 2008 |
Tyrosine, a carcinogen.
Topics: Humans; Neoplasms; Tyrosine | 1948 |
A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Topics: beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Humans; Kangai-1 Protein; Neoplasms; Phosphorylation; Tyrosine | 2008 |
Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor.
Topics: Angiogenesis Inhibitors; Aza Compounds; Binding Sites; Drug Design; Glycine; Integrin alpha5beta1; Integrin alphaVbeta3; Ligands; Macular Degeneration; Models, Molecular; Neoplasms; Protein Conformation; Sequence Homology, Amino Acid; Structure-Activity Relationship; Substrate Specificity; Tyrosine | 2008 |
Whole-body tyrosine flux in relation to energy expenditure in weight-losing cancer patients.
Topics: Aged; Body Weight; Energy Metabolism; Humans; Kinetics; Middle Aged; Neoplasms; Nutrition Disorders; Oxygen Consumption; Protein Biosynthesis; Tyrosine | 1984 |
Altered amino acid kinetics in rats with progressive tumor growth.
Topics: Animals; Body Weight; Cachexia; Dietary Proteins; Energy Intake; Female; Liver; Muscles; Neoplasm Staging; Neoplasms; Protein Biosynthesis; Proteins; Rats; Rats, Inbred Strains; Time Factors; Tyrosine | 1982 |
Protein-tyrosine kinases: potential targets for anticancer drug development.
Topics: Drug Design; Humans; Hydroquinones; Neoplasms; Phenols; Phosphotyrosine; Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 1994 |
Constitutive phosphorylation of Shc proteins in human tumors.
Topics: Adaptor Proteins, Signal Transducing; ErbB Receptors; GRB2 Adaptor Protein; Humans; Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Receptors, Platelet-Derived Growth Factor; Tumor Cells, Cultured; Tyrosine | 1995 |
Association of inhibition of cell growth by O-phospho-L-tyrosine with decreased tyrosine phosphorylation.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Drug Interactions; Female; Humans; Insulin; Liver Neoplasms; Mice; Neoplasm Proteins; Neoplasms; Ovarian Neoplasms; Phosphorylation; Phosphotyrosine; Proto-Oncogene Proteins pp60(c-src); Receptor, ErbB-2; Receptor, Insulin; Tumor Cells, Cultured; Tyrosine | 1996 |
Whole body protein metabolism in children with cancer.
Topics: Adolescent; Amino Acids; Carbon Isotopes; Child; Child, Preschool; Deuterium; Female; Humans; Kinetics; Leucine; Male; Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Tyrosine | 1996 |
Radiolabelled-tyrosine for the measurement of protein synthesis rate in vivo by positron emission tomography.
Topics: Animals; Carbon Radioisotopes; Humans; Models, Biological; Neoplasms; Protein Biosynthesis; Proteins; Tomography, Emission-Computed; Tyrosine | 1996 |
PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates.
Topics: Adult; Aged; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Neoplasms; Protein Biosynthesis; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 1997 |
Synthesis of isomers of 18F-labelled amino acid radiopharmaceutical: position 2- and 3-L-18F-alpha-methyltyrosine using a separation and purification system.
Topics: alpha-Methyltyrosine; Amino Acids; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Humans; Indicators and Reagents; Isomerism; Isotope Labeling; Methyltyrosines; Neoplasms; Radionuclide Imaging; Tyrosine | 1997 |
Influence of phosphotyrosine kinase inhibitors on adhesive properties of highly and poorly metastatic HT-29 colon carcinoma cells to collagen.
Topics: Benzoquinones; Cell Adhesion; Collagen; Genistein; HT29 Cells; Humans; Integrins; Lactams, Macrocyclic; Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Quinones; Receptors, Vitronectin; Rifabutin; Tyrosine | 1999 |
Do TNF-alpha-insensitive cancer cells escape alpha-tubulin nitrotyrosination?
Topics: Neoplasms; Nitric Oxide; Protein Processing, Post-Translational; Tubulin; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |
C-Cbl protein in human cancer tissues is frequently tyrosine phosphorylated in a tumor-specific manner.
Topics: Carcinoma; Humans; Neoplasm Proteins; Neoplasms; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Tumor Cells, Cultured; Tyrosine; Ubiquitin-Protein Ligases | 2000 |
Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking.
Topics: Animals; Apoptosis; Ascitic Fluid; Cell Communication; Cell Movement; Cytokines; Cytotoxicity, Immunologic; Free Radicals; Macrophages; Neoplasm Regression, Spontaneous; Neoplasms; Peritoneum; Rats; Rats, Wistar; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine | 2001 |
c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis.
Topics: Active Transport, Cell Nucleus; Animals; Arsenic; Binding Sites; Blotting, Western; Carcinogens; Cell Division; Cell Line; Enzyme Activation; Epithelium; ErbB Receptors; Female; Humans; Ligands; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Models, Biological; Neoplasms; Phenotype; Phosphorylation; Precipitin Tests; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Time Factors; Transcription Factor AP-1; Transfection; Tyrosine; Urinary Tract; Urogenital Neoplasms | 2002 |
Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met.
Topics: Actins; Animals; Blotting, Western; Cell Movement; DNA, Complementary; Flow Cytometry; G(M1) Ganglioside; Gangliosides; Hepatocyte Growth Factor; Mice; Neoplasms; Phosphorylation; Precipitin Tests; Proto-Oncogene Proteins c-met; Signal Transduction; Stress Fibers; Time Factors; Transfection; Tumor Cells, Cultured; Tyrosine | 2001 |
Antitryptic property of cancer-related glycoprotein EDC1.
Topics: Carboxypeptidases; Caseins; Chymotrypsin; Fibrinolysin; Glycoproteins; Humans; Leucyl Aminopeptidase; Neoplasms; Pancreatic Elastase; Pepsin A; Protein Binding; Tosyl Compounds; Trypsin Inhibitors; Tyrosine | 1978 |
On the levels of phenylalanine, tyrosine and tetrahydrobiopterin in the blood of tumor-bearing organisms.
Topics: Animals; Biopterins; Blood Proteins; Female; Humans; Hydroxylation; Male; Neoplasms; Neoplasms, Experimental; Phenylalanine; Protein Binding; Pteridines; Rats; Tyrosine | 1977 |
A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A-chain binds specifically to cultured cells and interferes with binding of several growth factors.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Cell Line; Cells, Cultured; CHO Cells; Cricetinae; DNA, Neoplasm; Endothelium, Vascular; Exons; Heparin; Humans; Kinetics; Macromolecular Substances; Mice; Molecular Sequence Data; Neoplasms; Peptides; Platelet-Derived Growth Factor; Receptors, Cell Surface; Receptors, Platelet-Derived Growth Factor; RNA Splicing; Substrate Specificity; Tyrosine | 1992 |
[Anticancer therapy with amino acid imbalance].
Topics: Amino Acids; Animals; Antineoplastic Agents; Arginine; Cysteine; Humans; Methionine; Neoplasms; Parenteral Nutrition, Total; Phenylalanine; Tyrosine; Valine | 1991 |
Effect on whole-body protein synthesis after institution of intravenous nutrition in cancer and non-cancer patients who lose weight.
Topics: Aged; Amino Acids; Cachexia; Energy Metabolism; Female; Humans; Male; Middle Aged; Neoplasms; Parenteral Nutrition, Total; Protein Biosynthesis; Tyrosine | 1991 |
Anti-O-phosphotyrosine antibodies in human sera.
Topics: Adolescent; Adult; Aged; Antibodies; Antibody Affinity; Child; Child, Preschool; Collagen Diseases; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infant; Infant, Newborn; Liver Diseases; Lung Diseases; Male; Middle Aged; Neoplasms; Nervous System Diseases; Phosphotyrosine; Tyrosine | 1985 |
Proteins phosphorylated on tyrosine as markers of human tumor cell lines.
Topics: Cell Line; ErbB Receptors; Humans; Molecular Weight; Neoplasm Proteins; Neoplasms; Oncogenes; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Tyrosine | 1987 |
[A method of detecting modifications of tyrosine residues in serum albumin].
Topics: Humans; Methods; Neoplasms; Serum Albumin; Tyrosine | 1988 |
Observations on predicted brain influx rates of neurotransmitter precursors. Effects of tumor, operative stress with tumor removal, and postoperative TPN of varying amino acid compositions.
Topics: Amino Acids; Blood-Brain Barrier; Brain; Female; Humans; Male; Neoplasms; Neurotransmitter Agents; Parenteral Nutrition, Total; Serum Albumin; Stress, Physiological; Surgical Procedures, Operative; Tryptophan; Tyrosine | 1987 |
Hereditary tyrosinemias (type I): a new vista on tyrosine toxicity and cancer.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Humans; Liver; Liver Neoplasms, Experimental; Neoplasms; Tyrosine | 1986 |
[Congenital disorders of tyrosine metabolism and their correction in children with tumors].
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Female; Homogentisic Acid; Humans; Male; Maternal-Fetal Exchange; Neoplasms; Phenylpropionates; Pregnancy; Tyrosine | 1987 |
[Disorders of tyrosine metabolism in children with tumors].
Topics: Adolescent; Child; Child, Preschool; Homogentisic Acid; Humans; Infant; Infant, Newborn; Neoplasms; Phenylpropionates; Tyrosine | 1986 |
Fasting plasma amino acid levels in cancer patients.
Topics: Adolescent; Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Esophageal Neoplasms; Fasting; Female; Humans; Lysine; Male; Middle Aged; Neoplasms; Tyrosine | 1985 |
The potential of coenzyme Q 10 (NSC-140865) in cancer treatment.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Chick Embryo; Cricetinae; Haplorhini; Humans; Lipid Metabolism; Metabolism, Inborn Errors; Mice; Neoplasms; Peroxides; Phenylalanine; Rabbits; Rats; Sarcoma 180; Succinate Dehydrogenase; Turkeys; Tyrosine; Ubiquinone | 1974 |
Studies on sequential metabolic alterations in spontaneous mammary carcinogenesis.
Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Animals; DNA, Neoplasm; Female; Mammary Glands, Animal; Mice; Neoplasms; Ribonucleases; RNA, Neoplasm; Tyrosine | 1967 |
The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid.
Topics: Adenocarcinoma, Scirrhous; Adenoma, Islet Cell; Adrenal Gland Neoplasms; Amyloidosis; Arthritis, Rheumatoid; Carcinoma; Endocrine System Diseases; Histocytochemistry; Humans; Microscopy, Electron; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Pheochromocytoma; Thyroid Neoplasms; Tryptophan Oxygenase; Tyrosine | 1972 |
[Biochemical diagnosis of pheochromocytoma, neuroblastoma and other neuro-ectodermal neoplasms].
Topics: Adolescent; Adult; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Electrophoresis, Paper; Epinephrine; Female; Ganglioneuroma; Glycols; Histocytochemistry; Humans; Infant; Male; Melanoma; Methods; Middle Aged; Neoplasms; Nervous System Diseases; Neuroblastoma; Norepinephrine; Normetanephrine; Pheochromocytoma; Sympathetic Nervous System; Tyramine; Tyrosine; Vanilmandelic Acid | 1972 |
Anti-tumor effect of the amino acid minosine.
Topics: Alanine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dose-Response Relationship, Drug; Genitalia; Hair; Male; Melanoma; Neoplasms; Plant Extracts; Pyridones; Rats; Tyrosine | 1973 |
The histochemical tyrosine-dopa reaction for tyrosinase and its use in localizing tyrosinase activity in mast cells.
Topics: Animals; Catechol Oxidase; Dihydroxyphenylalanine; Histocytochemistry; Humans; Mast Cells; Melanoma; Methods; Microscopy, Electron; Neoplasms; Pigments, Biological; Rats; Tyrosine | 1969 |
[Concentration changes of free amino acids in blood plasma of patients under radiotherapy. (With reference to statistical results)].
Topics: Alanine; Amino Acids; Bronchial Neoplasms; Carcinoma; Cobalt Isotopes; Dysgerminoma; Esophageal Neoplasms; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leucine; Male; Neoplasms; Phenylalanine; Proline; Radiation Injuries; Sex Factors; Statistics as Topic; Tyrosine; Urinary Bladder Neoplasms; Valine | 1972 |
Immunosuppressive effects of L-asparaginase.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Alanine; Antibody Formation; Antigens; Asparaginase; Asparagine; Breast Neoplasms; Carcinoma; Child, Preschool; Female; Glutamates; Hemocyanins; Humans; Hypersensitivity, Delayed; Immunoglobulins; Immunosuppressive Agents; Lectins; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocytes; Lysine; Male; Middle Aged; Neoplasms; Osteosarcoma; Tyrosine | 1970 |
Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer.
Topics: Animals; Blood; Female; Glucosamine; Humans; Hyaluronoglucosaminidase; Mucus; Neoplasms; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Tyrosine; Uterine Cervical Neoplasms; Uterine Neoplasms | 1970 |
Levels of adrenal catecholamine-synthesizing enzymes after postmortem treatment in rats and after necropsy in human beings.
Topics: Adrenal Glands; Adult; Aged; Alcoholism; Animals; Autopsy; Cardiovascular Diseases; Dopamine; Epinephrine; Female; Freezing; Humans; Liver Cirrhosis; Male; Middle Aged; Mixed Function Oxygenases; Neoplasms; Postmortem Changes; Rats; Substance-Related Disorders; Time Factors; Tissue Preservation; Transferases; Tyrosine; Wounds and Injuries | 1971 |
Host--tumour relationship. XXVII. The saccharide components of seromucoid in patients with tumours.
Topics: Blood Proteins; Fucose; Hexoses; Humans; Mucoproteins; Neoplasms; Tyrosine | 1968 |
[Relations between phenylalanine and cancerous cells].
Topics: Amino Acids; Animals; Diet Therapy; Humans; Neoplasms; Phenylalanine; Proteins; Tyrosine | 1968 |